More Microvascular Complications Raise Heart and Death Risk in Diabetes, reveals study
The researchers have discovered that the increase in microvascular complications in individuals who have type 2 diabetes greatly raises their risk of cardiovascular events and mortality. The results highlight the importance of early intervention and individualized management in patients with poly-microvascular complications, since such patients are at significantly increased risk of heart attack, stroke, and all-cause mortality. The study was published in Diabetes Research and Clinical Practice by Chun-Ta Huang and fellow researchers.
4,527 people with type 2 diabetes took part in the study. Participants were divided into groups according to how many microvascular diseases they had:
• Group 0: no microvascular complications
• Group 1: one microvascular complication
• Group 2: two or more microvascular complications
The main outcome that was measured was a composite of three severe health events: stroke, myocardial infarction (heart attack), and death. Participants were followed up for a median of 3.3 years by researchers to monitor these events.
Key Findings
A clear dose-dependent association was shown by the study between the amount of microvascular complications and severe health outcomes:
• 13.07 per 1,000 person-years for Group 0
• 22.98 per 1,000 person-years for Group 1
• 35.52 per 1,000 person-years for Group 2
• Group 2 patients experienced the greatest risk of a primary outcome with a hazard ratio (HR) of 1.73 and a 95% confidence interval (CI) of 1.16–2.59 when compared to patients without microvascular complications.
When the analysis is performed for particular secondary outcomes:
• The risk of stroke was considerably greater among Group 2 patients (HR: 2.61; 95% CI: 1.19–5.73)
• The risk of myocardial infarction also rose in Group 2 (HR: 1.67; 95% CI: 1.03–2.70)
Overall, the occurrence of more than one microvascular complication in type 2 diabetic patients drastically increases the risk of stroke, myocardial infarction, and mortality. This Taiwanese experience highlights the need to recognize and treat microvascular diseases at the early stages of diabetes. A focused, preventive approach may lower the burden of macrovascular disease and enhance long-term outcomes in this high-risk group.
Reference:
Chun-Ta Huang, Chiao-Ya Chan, Ming-Chieh Tsai, Shih-Ming Chuang, Sung-Chen Liu, Ming-Nan Chien, Chih-Yuan Wang, Horng-Yih Ou, Chun-Chuan Lee, Microvascular diseases predict mortality and cardiovascular events in type 2 diabetes: A retrospective cohort study, Diabetes Research and Clinical Practice, 2025, https://doi.org/10.1016/j.diabres.2025.112356.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.